Follow Us:





Supported By
Presentation Sponsor
Sponsorship
For Sponsorship Opportunities, Please Contact
Julia Zhu
Tel: +86-21-61573922
Mobile: 13795260497
Email: Julia.Zhu@ubm.com
Organised By
Novel Drug Delivery System (NDDS) & Clinical Trail Management China 2013
Confirmed Speakers
 
 
Peng Wang
Peng Wang
President
Yabao Pharmaceutical-Beijing Pharmaceutical Research Institute
Weihu Fan
Weihu Fan
Former Director
Department of Cardiology-Huashan Hospital
Yaling Wang
Yaling Wang
Director of Fundamental Pharmaceutics
Merck
Fang Weijie
Fang Weijie
Director, BiopharmaceuticalFormulation
Zhejiang Hisun Pharmaceutical Co. Ltd
Qinghua Chen
Qinghua Chen
Researcher/PhD Supervisor
Shanghai Institute of Pharmaceutical Industry
Minxian Song
Minxian Song
Director
China Pharmaceutical Excipients Committee (CPEC)
Baoling Duan
Baoling Duan
CEO
NCPC New Drug R&D Co., Ltd
Ping He
Ping He
CEO
Fosun Pharma-SunTec Pharma
Fred Li
Fred Li
Vice General Manager
Hua Medicine
Qiming Zhang
Qiming Zhang
Director
National Institutes for Food and Drug Control
Wei Liang
Wei Liang
Researcher
Institute of Biophysics, Chinese Academy of Sciences
Aiswariya Chidambaram
Aiswariya Chidambaram
Senior Research Analyst
Frost & Sullivan
Tao Zhang
Tao Zhang
Chief Engineer
Chongqing Pharmaceutical Research Institute Co., Ltd.
Amer Alghabban
Amer Alghabban
Director
Global R&D and GVP Quality Assurance, Merck Serono
Mingqiu Lu
Mingqiu Lu
Formulation Group Leader
Roche R&D Center China
Chaofeng Liang
Chaofeng Liang
Deputy Director
Guangzhou Institute of Pharmaceutical Industry
Wei Wu
Wei Wu
Professor
School of Pharmacy, Fudan University
 
 
Sponsor Opportunities
More exclusive sponsor opportunities, please CLICK HERE
Background
  • Following the huge success of NDDS China 2011 & 2012, CPhI and UBM Conferences will host 3rd NDDS China 2013 on 27-28th, November in Crowne Plaza Century Park Shanghai, China.
  • China’s drug delivery system and formulation research level lags behind but with great potential. China National 12th Five-Year Plan for Key New Drug R&D Projects has set Novel Drug Delivery System as a key development trend. How to realize product differentiation and enhance the research and commercialization level by making use of the latest drug delivery system and formulation strategy has become an urgent problem for pharmaceutical companies to solve.
  • Novel drug delivery is one of the fastest growing pharmaceutical sectors. The three most promising drug delivery systems in China are sustained/controlled release oral DDS, injection DDS and nanopartical DDS. At present there are over 1400 sustained/controlled release drugs worldwide. Sustained/controlled oral release formulation is one of the hotspots with annual increase in new product application and registration.
  • In recent years, Novel Drug Delivery Systems (NDDS) has captured the interest all the big and small pharmaceutical re-search organizations, pioneering there research to devise newer strategies for effectively delivering the drugs in the body or improvise the existing technologies to enhance their efficiency in the body.
  • The newly improving delivery systems of the originally available drugs are not only beneficial for the patients but also less complicated inters of offering needle free delivery and reduction in the dose of the active ingredients.
  • Figures and Facts:
    The global Drug Delivery Systems market is projected to reach $196.4 billion by 2014.
    There are over 1400 sustained/controlled release drugs worldwide.
    Global injectable drug delivery market is expected to be worth $29,981 million by 2015.
Why Should You Attend?
  • Deep understands about the drug delivery system development and industrializing insights & gain the latest know-how about novel drug delivery and application status-quos
  • Meeting with 20+ industrial expert and speakers、50+Pharmaceutical Companies、120+decision-makers interacting
  • Finding newer ways of doing NDDs business and finally providing the “value addition” to our respective pharmaceutical research businesses
  • Focus on novel strategies for drug delivery, as well as clinical trail’s latest updates to drive your market share significantly;
  • Learn on the applications of innovative DDS for treating major diseases to advance the drug portfolio industrialization pathways;
  • Listen to the case-studies by the pioneers in the field of drug delivery technologies to differentiate your product competitiveness step by step;
Who Should Attend?

By Industry

 

By Job Title

 
Pharma Manufacturers
Government & Supervision
Research Institutes
Drug Deliver Technology Supply
CROs & Platform Provider
Device & Equipment Provider
Ingredient, Excipient & Material Supply
Laboratory & Instrument
Others
VPs, GMs, CSOs, CTOs
Heads of R&D/Formulation
Heads of Drug Deliver System
Pharma Analysis
Drug/Product Development
Business Development
Strategy & Market
Technical Transformation
Others
Past On-Site Pictures
On-site pictures:

Media Partners